ATE311402T1 - Peptidnukleinsäuren mit erhöhter bindungsaffinität, sequenzspezifität und löslichkeit - Google Patents

Peptidnukleinsäuren mit erhöhter bindungsaffinität, sequenzspezifität und löslichkeit

Info

Publication number
ATE311402T1
ATE311402T1 AT97935053T AT97935053T ATE311402T1 AT E311402 T1 ATE311402 T1 AT E311402T1 AT 97935053 T AT97935053 T AT 97935053T AT 97935053 T AT97935053 T AT 97935053T AT E311402 T1 ATE311402 T1 AT E311402T1
Authority
AT
Austria
Prior art keywords
solubility
nucleic acids
peptide nucleic
sequence specificity
binding affinity
Prior art date
Application number
AT97935053T
Other languages
English (en)
Inventor
Peter E Nielsen
Michael Egholm
Rolf H Berg
Ole Buchardt
Original Assignee
Buchardt Dorte
Nielsen Peter Eigil Prof Dr
Michael Egholm
Berg Rolf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/686,114 external-priority patent/US6414112B1/en
Priority claimed from US08/686,116 external-priority patent/US5714331A/en
Priority claimed from US08/685,484 external-priority patent/US5719262A/en
Priority claimed from US08/686,113 external-priority patent/US5766855A/en
Application filed by Buchardt Dorte, Nielsen Peter Eigil Prof Dr, Michael Egholm, Berg Rolf filed Critical Buchardt Dorte
Application granted granted Critical
Publication of ATE311402T1 publication Critical patent/ATE311402T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT97935053T 1996-07-24 1997-07-24 Peptidnukleinsäuren mit erhöhter bindungsaffinität, sequenzspezifität und löslichkeit ATE311402T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/686,114 US6414112B1 (en) 1991-05-24 1996-07-24 Peptide nucleic acids having 2,6-diaminopurine nucleobases
US08/686,116 US5714331A (en) 1991-05-24 1996-07-24 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
US08/685,484 US5719262A (en) 1993-11-22 1996-07-24 Peptide nucleic acids having amino acid side chains
US08/686,113 US5766855A (en) 1991-05-24 1996-07-24 Peptide nucleic acids having enhanced binding affinity and sequence specificity
US5100297P 1997-05-29 1997-05-29
PCT/US1997/012811 WO1998003542A1 (en) 1996-07-24 1997-07-24 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility

Publications (1)

Publication Number Publication Date
ATE311402T1 true ATE311402T1 (de) 2005-12-15

Family

ID=27535143

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97935053T ATE311402T1 (de) 1996-07-24 1997-07-24 Peptidnukleinsäuren mit erhöhter bindungsaffinität, sequenzspezifität und löslichkeit

Country Status (7)

Country Link
EP (1) EP0960121B1 (de)
JP (2) JP3306073B2 (de)
AT (1) ATE311402T1 (de)
AU (1) AU717387B2 (de)
CA (1) CA2261566A1 (de)
DE (1) DE69734783T2 (de)
WO (1) WO1998003542A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985558A (en) * 1997-04-14 1999-11-16 Isis Pharmaceuticals Inc. Antisense oligonucleotide compositions and methods for the inibition of c-Jun and c-Fos
DE19653646A1 (de) * 1996-12-20 1998-06-25 Hoechst Ag Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung
US6326479B1 (en) 1998-01-27 2001-12-04 Boston Probes, Inc. Synthetic polymers and methods, kits or compositions for modulating the solubility of same
US7892737B2 (en) 2005-06-30 2011-02-22 Life Technologies Corporation Compositions, kits and methods pertaining to stability modulation of PNA oligomer/nucleic acid complexes
WO2007120265A2 (en) 2005-11-14 2007-10-25 Applera Corporation Coded molecules for detecting target analytes
JP2009543058A (ja) 2006-06-30 2009-12-03 アプライド バイオシステムズ， エルエルシー 結合相互作用を分析する方法
DE102006034319A1 (de) 2006-07-21 2008-01-31 Ugichem Gmbh Chirale mit Phosponsäurester- oder Phosphonsäure- substituierte Verbindungen
US20100284959A1 (en) * 2008-01-23 2010-11-11 Gene Arrest Ltd. Sequence specific double-stranded dna/rna binding compounds and uses thereof
CN102282155B (zh) 2008-12-02 2017-06-09 日本波涛生命科学公司 磷原子修饰的核酸的合成方法
RU2612521C2 (ru) 2009-07-06 2017-03-09 Онтории, Инк. Новые пролекарства нуклеиновых кислот и способы их применения
JP5868324B2 (ja) 2010-09-24 2016-02-24 株式会社Wave Life Sciences Japan 不斉補助基
CN103796657B (zh) 2011-07-19 2017-07-11 波涛生命科学有限公司 合成官能化核酸的方法
CA2879066C (en) 2012-07-13 2019-08-13 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant
KR102213609B1 (ko) 2012-07-13 2021-02-08 웨이브 라이프 사이언시스 리미티드 키랄 제어
PL2872485T3 (pl) 2012-07-13 2021-05-31 Wave Life Sciences Ltd. Asymetryczna grupa pomocnicza
KR101830700B1 (ko) 2013-11-11 2018-02-21 주식회사 파나진 클램핑 프로브 및 검출 프로브를 이용한 다중 표적핵산 검출방법
JPWO2015108048A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
JPWO2015108047A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
US10322173B2 (en) 2014-01-15 2019-06-18 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
BR112016016400A2 (pt) 2014-01-16 2017-10-03 Wave Life Sciences Ltd Composições de oligonucleotídeos quiralmente controlados, seu uso, sua composição farmacêutica, e métodos
DE102014007158A1 (de) * 2014-05-16 2015-11-19 Ugichem Gmbh Neue Peptid-Nukleinsäuren-Monomere und -Oligomere
EP3498844B1 (de) 2016-08-09 2022-09-28 Seasun Therapeutics Peptidnukleinsäurekomplex mit verbesserter zellpermeabilität und pharmazeutische zusammensetzung damit
KR102262260B1 (ko) * 2018-02-08 2021-06-09 주식회사 시선테라퓨틱스 엔도좀 탈출능을 갖는 펩티드 핵산 복합체 및 이의 용도
KR102484332B1 (ko) 2018-02-08 2023-01-04 주식회사 시선테라퓨틱스 핵산 복합체를 함유하는 피부 투과성 전달체 및 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS200063B1 (cs) * 1978-08-24 1980-08-29 Milan Strasak Způsob přípravy alkylen-Ν,Ν '-bis-histidinů
JPS6163661A (ja) * 1984-09-05 1986-04-01 Microbial Chem Res Found ヒスタジン関連化合物
AU5410786A (en) * 1985-03-04 1986-09-11 Fujisawa Pharmaceutical Co., Ltd. Amino acid derivatives and processes for preparation thereof
US5166315A (en) * 1989-12-20 1992-11-24 Anti-Gene Development Group Sequence-specific binding polymers for duplex nucleic acids
WO1986005519A1 (en) * 1985-03-15 1986-09-25 James Summerton Polynucleotide assay reagent and method
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
DE4408528A1 (de) * 1994-03-14 1995-09-28 Hoechst Ag Peptid-Oligonucleotid-Derivate, deren Herstellung und Verwendung
DE19532553A1 (de) * 1995-09-04 1997-03-06 Hoechst Ag Verfahren zur Herstellung substituierter N-Ethyl-Glycinderivate

Also Published As

Publication number Publication date
JP3306073B2 (ja) 2002-07-24
JP2002105059A (ja) 2002-04-10
DE69734783D1 (de) 2006-01-05
AU717387B2 (en) 2000-03-23
DE69734783T2 (de) 2006-08-17
JP2000503671A (ja) 2000-03-28
EP0960121A4 (de) 2003-05-28
AU3808197A (en) 1998-02-10
EP0960121A1 (de) 1999-12-01
CA2261566A1 (en) 1998-01-29
EP0960121B1 (de) 2005-11-30
WO1998003542A1 (en) 1998-01-29

Similar Documents

Publication Publication Date Title
ATE311402T1 (de) Peptidnukleinsäuren mit erhöhter bindungsaffinität, sequenzspezifität und löslichkeit
KR0133131B1 (en) Peptide nucleic acids
WO1994025477A3 (en) Novel peptide nucleic acids
ZA971208B (en) Sugar-modified gapped oligonucleotides.
WO1996032496A3 (en) Covalently linked oligonucleotide minor groove binder conjugates
EP1762619A3 (de) Multi-tumor abweichende wachstumsgene
DE69527857D1 (de) Peptid-nukleinsäure-konjugate
CA2320100A1 (en) High affinity nucleic acid ligands of complement system proteins
EP1741780A3 (de) Ologonukleotidliganden mit höher Affinität für Wachstumsfaktoren
PT1210357E (pt) Oligonucleótido-tiofosforamidatos n3'→p5': sua síntese e utilização
EP1975172A3 (de) Hochaffine TGFß-Nukleinsäureliganden und -inhibitoren
ATE217906T1 (de) Methoden zur zielrichtung von dna
DE60041267D1 (de) 2'-o-acetamido-modifizierte monomere und oligomere
EP1147123A4 (de) Neuartige geruchsrezeptoren in drosophila
WO2001079216A3 (de) Polyamidnukleinsäure-derivate, mittel und verfahren zur ihrer herstellung
WO2002016617A3 (en) Myrosinase from brevicoryne brassicae
WO1996012397A3 (en) Recombinant antibody capable of binding to pna/nucleic acid complexes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties